Clinical Trial Update: EXCEL Clinical Trial (Universal Registry)

View source ↗

Summary

An update indicating the EXCEL trial comparing PCI with everolimus-eluting stents to CABG for left main coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Restenosis
• Coronary Stenosis
• Left Main Coronary Artery Disease
• Myocardial Ischemia
• Stent Thrombosis
• Total Occlusion of Coronary Artery

Drugs mentioned

• XIENCE everolimus-eluting stent (everolimus)

Snippet

Sponsor: Abbott Medical Devices | Conditions: Chronic Coronary Occlusion, Left Main Coronary Artery Disease | Status: COMPLETED